Intro
The Alberta cattle industry accounts for over $470 million towards Alberta’s GDP (Stats Can, 2017). Since it is a huge economic driver for the province, maintaining healthy agricultural practices are extremely important. BRD is currently treated by giving the cattle antibiotics with the hope that the infection will pass (Taylor et al., 2010). This affects farmers as it can cause cattle and economic losses.
Currently, no vaccines against these BRD infections are used by producers. Treatment of sick cattle is usually through mass antibiotic administration through feed or water. Calves that are high risk for BRD are metaphylactically treated with antibiotics (Taylor et al., 2010). However, mass antimicrobial administration represents major antimicrobial consumption and does not always result in decreases in cattle mortality (Baptiste & Kyvsgaard, 2017). Unnecessary blanket treatment of animals can also lead to the increased spread of antimicrobial resistance genes and the decrease of antibiotic efficacy (Whiteley et al., 1992).
We envision Bo-Find as a hand-held device that vets or farmers can use to detect Bovine Respiratory Disease (BRD) in cattle with minimal sample preparation (Figure 1). Current detection methods require extensive culturing and DNA preparation prior to pathogen identification or detection. Bo-Find will use a simple colour-change to give users a yes/no readout for infection. All of our tests will be able to be carried out within one hour, speeding up the detection process.
Figure 1. Bo-Find will incorporate on-site nasal swabs with recombinase-polymerase amplification technology to get rapid diagnostic results.